CION Ameerpet
Precancer Explained · Reviewed by CION Oncologists · NABH Accredited
Endometrial Hyperplasia — It Is Not Cancer
A biopsy report that says endometrial hyperplasia is one of the most frightening pieces of paper a woman can be handed, because the word sits so close to words that mean something far worse. So the important thing goes first. Hyperplasia is not cancer. It is a lining of the uterus that has grown too thick because oestrogen has been acting on it without enough progesterone to balance it. What happens next depends almost entirely on one line further down the report — whether the pathologist saw atypia. That single word separates a condition usually managed with hormones from a genuine precancer that is treated seriously.
- Hyperplasia is benign — a thickened, overgrown lining — a hormone problem, not a malignancy
- Two types, two different situations — without atypia, and with atypia (also called EIN)
- Without atypia rarely becomes cancer — most cases settle with hormone treatment alone
- With atypia is treated as precancer — higher risk, closer follow-up, and usually surgery is advised
17+
Cancer Specialists
on Panel
on Panel
35+
Centres
Across India
Across India
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
What Endometrial Hyperplasia Actually Is
The endometrium is the lining of the uterus. In a normal cycle, oestrogen tells it to grow in the first half of the month and progesterone then tells it to stop growing, mature and — if there is no pregnancy — shed as a period. Growth followed by a brake, every month.
Hyperplasia is what happens when the growth signal keeps arriving and the brake does not. The lining goes on thickening, month after month or year after year, and the glands within it become crowded and irregular. That is the whole of it: too much oestrogen relative to progesterone, acting on the lining for too long.
- It is a hormone problem before it is anything else. Almost everything that causes hyperplasia is something that raises oestrogen, removes progesterone, or both — which is also why so much of the treatment is simply putting the missing progesterone back.
- Bleeding is how it announces itself. An overgrown, unstable lining sheds unpredictably. Heavy periods, bleeding between periods, or any bleeding after the menopause are the usual reasons a woman ends up having a biopsy in the first place.
- Only a biopsy can name it. A scan can show that a lining is thick. It cannot show what the cells look like, and the cells are the entire question. See what an endometrial biopsy involves.
If your lining was reported as thickened on a scan and you are waiting for a biopsy, this page on endometrial thickness explains what that measurement does and does not tell you.
Did You Know? The two types of hyperplasia are not two points on one scale — they behave like different conditions. Hyperplasia without atypia progresses to cancer in fewer than 5 in 100 women over 20 years, and a large share resolves on its own or with hormone treatment. Atypical hyperplasia is a different matter: long-term follow-up puts progression at roughly a quarter to a third of women over about two decades, and when the uterus is removed for atypical hyperplasia a cancer is already found alongside it in a substantial minority of cases — in one large prospective surgical series, around four in ten. That is precisely why the two are not managed the same way. Sources: World Health Organization classification of tumours of female reproductive organs; RCOG / BSGE Green-top Guideline No. 67 on the management of endometrial hyperplasia; NCCN Clinical Practice Guidelines in Oncology — Uterine Neoplasms; ESMO–ESGO–ESTRO consensus on endometrial carcinoma.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
The Two Types — and Why the Difference Is Everything
Older reports used four categories (simple, complex, and each of those with or without atypia). Current practice, following the World Health Organization classification, uses two. If your report uses the older wording, the question to ask is still the same one: was there atypia?
| Hyperplasia without atypia | Atypical hyperplasia / EIN | |
|---|---|---|
| What the pathologist sees | Crowded, overgrown glands, but the individual cells still look normal. The architecture has changed; the cells have not. | Crowded glands and cells that look abnormal — larger, irregular nuclei, a changed appearance. Also reported as endometrioid intraepithelial neoplasia (EIN). |
| Is it cancer? | No. It is a benign response to prolonged oestrogen stimulation. | No — but it is a recognised precancer, and a cancer is sometimes found alongside it once the whole uterus is examined. |
| Risk of progressing | Low. Under 5 in 100 women over 20 years, and many cases regress on their own or with treatment. | Substantial. Long-term follow-up puts it at roughly a quarter to a third of women over about two decades. |
| Usual first-line treatment | Progestin hormone therapy — commonly a hormone-releasing intrauterine device, sometimes tablets — with a repeat biopsy to confirm it has cleared. See this page. | Total hysterectomy is the standard recommendation. Hormone treatment with close biopsy surveillance is offered to women who want to preserve fertility, or who cannot have surgery. See atypical hyperplasia. |
| What follow-up looks like | Repeat sampling until two clear results, then a return to routine care if the underlying cause has been addressed. | Intensive: repeat biopsies at short intervals if the uterus is being kept, and a clear plan for surgery once childbearing is complete. |
If you take one thing from this page, take this: find the word atypia in your report and find out whether it says present or absent. Two women can both be told they have “endometrial hyperplasia” and be in genuinely different situations. If the report is ambiguous, or uses the older four-part wording, ask for it to be reviewed rather than guessing — and bring it to someone who will look at the slides, not just the summary line.
Not Sure Which Type Your Report Describes?
Bring the biopsy report. Forty-five minutes is long enough to go through it properly and to explain what follows from it.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
A Precancer Found Is a Cancer Prevented
Hyperplasia is one of the few points in this disease where the outcome can genuinely be changed by acting early. That is a good position to be in.
What Makes the Lining Overgrow
Nearly every cause is a version of the same thing — oestrogen without enough progesterone to oppose it. Several of these are modifiable, which is why treating hyperplasia and treating its cause are two separate jobs.
Most common
Excess Body Weight
Fat tissue makes oestrogen of its own, so it keeps stimulating the lining long after the ovaries have stopped. It is the single biggest driver. See weight and endometrial risk.
Common
Cycles Without Ovulation
If an egg is not released, no progesterone follows, so the lining grows unopposed. This is the mechanism behind PCOS and behind irregular perimenopausal cycles.
Common
Oestrogen Without Progesterone
Hormone replacement given as oestrogen alone, in a woman who still has her uterus, removes the brake entirely. This is why a progesterone component is added. See oestrogen-only HRT.
Metabolic
Diabetes and Insulin Resistance
These travel with excess weight and appear to add risk of their own. It matters regionally: Telangana and Andhra Pradesh carry a heavy metabolic disease burden. See diabetes and risk.
Treatment-related
Hormonal Breast Cancer Treatment
Some hormonal treatments used after breast cancer act on the uterine lining in the opposite way to how they act on the breast, and thicken it. Bleeding is what triggers investigation, not routine scanning.
Inherited
Lynch Syndrome
An inherited condition that raises the lifetime risk of endometrial cancer substantially and can present at a younger age. Worth considering when hyperplasia appears early. See Lynch syndrome.
Hyperplasia on Your Biopsy Report?
We will tell you which type it is, what the risk actually is for you, and what treatment is reasonable. The opinion is free.
The Two Ways This Diagnosis Gets Misread
Hearing “hyperplasia” and hearing “cancer”
Most women who are told they have hyperplasia will never develop endometrial cancer, and the commonest form is treated with a hormone device fitted in an outpatient clinic. The fear is understandable and largely misplaced. What is required is treatment and a repeat biopsy — not a rush into surgery. Ask what type you have before you decide how worried to be.
Hearing “not cancer” and stopping there
The opposite error, and the more dangerous one. Atypical hyperplasia is genuinely not cancer, and it is also the reason a hysterectomy is usually recommended — because of what it can become and what may already sit beside it. A woman reassured that it is benign, who then misses her follow-up biopsies, has been failed by the explanation rather than the diagnosis.
How It Is Found, and What Treatment Involves
The route in is almost always bleeding. A scan measures the lining and looks at the shape of the cavity; if the lining is thickened, or if bleeding continues regardless, tissue is sampled. Sampling is usually done in the clinic with a fine flexible tube, and takes a few minutes. Where the cavity needs to be seen directly — a suspected polyp, a previous sample that was inconclusive, persistent bleeding — a hysteroscopy is done instead, which lets the gynaecologist look inside the uterus and take a targeted sample.
Treatment then follows the report, and follows the cause:
- Restoring the missing progesterone. A hormone-releasing intrauterine device delivers progestin directly to the lining and is first-line for hyperplasia without atypia in current guidance; tablets are an alternative where a device is unsuitable. See how hyperplasia is treated.
- Proving it has worked. Treatment is not judged by symptoms alone. Repeat biopsies confirm the lining has returned to normal, and the interval between them depends on which type you had.
- Surgery where atypia is present. Removing the uterus both treats the precancer and answers the question of whether a cancer is already there. For women who want to conceive, hormone treatment with intensive surveillance is a recognised alternative — see hyperplasia and fertility.
- Treating the cause, not only the lining. If nothing changes about the oestrogen exposure that produced the hyperplasia, the hyperplasia has a route back. Weight, blood sugar and hormone medication are all part of the treatment plan, not separate from it.
Wondering about the risk of it turning into cancer specifically? That is covered in detail on will hyperplasia turn into cancer.
Everything on Endometrial Hyperplasia
This page is the starting point. Each guide below goes one level deeper into a part of it.
- Atypical endometrial hyperplasia (EIN) — the precancer
- Hyperplasia without atypia — risk & management
- How endometrial hyperplasia is treated
- Progestin therapy for endometrial hyperplasia
- The hormone IUD for endometrial hyperplasia
- Symptoms of endometrial hyperplasia
- What causes endometrial hyperplasia
- Can hyperplasia come back after treatment?
- Endometrial hyperplasia & fertility
- Will hyperplasia turn into cancer? (risk by type)
- Follow-up & biopsy monitoring for hyperplasia
Why Women in Hyderabad Bring a Hyperplasia Report to CION
A precancer is the point at which careful management changes the outcome. It deserves more than a five-minute appointment.
Slides reviewed, not just the summary line
Biopsy in the same visit
Hormone treatment before surgery, where that is right
Fertility taken seriously
Tumour board for every case that needs one
Decisions for healing, not billing
Take The Next Step
One Word in Your Report Decides What Happens Next
Find out which word it is, from someone who will explain what follows from it. One appointment is usually enough.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Endometrial Hyperplasia — Frequently Asked Questions
Is endometrial hyperplasia cancer?
No. Endometrial hyperplasia is a benign overgrowth of the uterine lining caused by oestrogen acting on it without enough progesterone to balance it. It is not a malignancy and it is not staged or treated as one. What matters is which of the two types you have. Hyperplasia without atypia is a hormone problem that seldom progresses and is usually managed with progestin treatment. Atypical hyperplasia, also reported as EIN, is classed as a precancer: it is still not cancer, but it carries a real risk of becoming one and a cancer is sometimes found alongside it when the uterus is examined in full. That is why the two are managed so differently.
What does it mean if my report says "without atypia"?
It means the pathologist saw a lining that had overgrown, with glands that were crowded and irregular, but the individual cells still looked normal. This is the commoner and much less worrying of the two types. Progression to cancer is uncommon — under 5 in 100 women over 20 years in long-term follow-up — and a substantial proportion of cases resolve on their own or with hormone treatment. Standard management is progestin therapy, most often a hormone-releasing intrauterine device, with repeat biopsies to confirm the lining has returned to normal. Treating the underlying cause, such as excess weight or unopposed oestrogen, matters just as much as treating the lining.
Do I need a hysterectomy for endometrial hyperplasia?
For hyperplasia without atypia, no — surgery is not the first-line treatment and most women are managed with hormone therapy and repeat sampling. Hysterectomy is generally reserved for women who do not respond to hormone treatment, whose hyperplasia keeps returning, or who cannot tolerate the follow-up. For atypical hyperplasia the recommendation is different: total hysterectomy is the standard approach, because it removes the precancer and simultaneously answers whether a cancer is already present. Even then it is not the only option — women who want to preserve fertility can be offered hormone treatment with intensive biopsy surveillance, and that decision should be made with a specialist rather than by default.
Can endometrial hyperplasia go away on its own?
Hyperplasia without atypia often does, particularly when the hormonal situation that caused it changes — an anovulatory phase passes, unopposed oestrogen is stopped, or significant weight is lost. That said, "often" is not "reliably", and spontaneous resolution is not something to plan around. Guidelines still recommend treatment and, importantly, repeat biopsies to confirm the lining has actually returned to normal rather than assuming it has because the bleeding settled. Atypical hyperplasia is different: it should not be watched in the hope it will regress, because the risk of progression and of concurrent cancer is too high for that to be a reasonable strategy.
What happens if endometrial hyperplasia is left untreated?
It depends entirely on the type, which is the recurring theme of this page. Untreated hyperplasia without atypia will most often continue to cause abnormal bleeding, which becomes its own problem — anaemia, disruption, repeated investigation — while the risk of it becoming cancer stays low. Untreated atypical hyperplasia is a genuinely different proposition: a substantial minority of women progress to endometrial cancer over the following years, and in some cases a cancer is already present but has not yet been sampled. Neither type should be ignored, but only one of them is urgent. If you have been told you have hyperplasia and no follow-up plan was made, ask what type it was and what the plan is.
Medical disclaimer: This page explains a biopsy finding and is reviewed by a CION oncologist. It describes how endometrial hyperplasia is classified and managed in general terms, following the World Health Organization classification and current NCCN, RCOG/BSGE and ESMO guidance. It is not an interpretation of your individual biopsy report, and the figures quoted describe groups of women rather than predicting what will happen to any one of them. If you are bleeding abnormally, see a doctor.